Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

Peer i-Coaching for Activated Self-management Optimization in Adolescents and Young Adults With Chronic Conditions

Outcome
Primary endpoint: 1 of 2 posted analyses statistically significant
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
29 October 2019
Ended
19 June 2024
Enrollment
222 participants
Sites
1
Primary outcomes
Change in Self-management as Measured by the Partners in Health Scale; Patient Activation as Measured by the Patient Activation Measure (PAM-13)
Sponsor type
Academic / other
Results posted
28 July 2025
Last update
17 July 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Primary endpoint: 1 of 2 posted analyses statistically significantAs posted on ClinicalTrials.gov ↗, registry record of 17 July 2026
Primary outcome
Change in Self-management as Measured by the Partners in Health ScaleBaseline: PiCASO Intervention Group: 6.7 (0.7), n = 147Baseline: Attention Control Group: 6.5 (0.8), n = 753 months: PiCASO Intervention Group: 6.8 (0.7), n = 1473 months: Attention Control Group: 6.6 (0.8), n = 756 months: PiCASO Intervention Group: 6.9 (0.8), n = 1476 months: Attention Control Group: 6.6 (0.8), n = 759 months: PiCASO Intervention Group: 7.0 (0.8), n = 1479 months: Attention Control Group: 6.6 (0.8), n = 7512 months: PiCASO Intervention Group: 7.1 (0.8), n = 14712 months: Attention Control Group: 6.6 (0.9), n = 75PiCASO Intervention Group vs Attention Control Group: p = 0.0034; Multi-level mixed effects (statistically significant against the posted threshold 0.05; outcome 1, analysis 1)Values: mean score on a scale, Standard DeviationTime frame: baseline, 3, 6, 9, and 12 months
Primary outcome
Patient Activation as Measured by the Patient Activation Measure (PAM-13)Baseline: PiCASO Intervention Group: 70.0 (8.4), n = 147Baseline: Attention Control Group: 68.8 (8.7), n = 753 months: PiCASO Intervention Group: 72.4 (9.2), n = 1473 months: Attention Control Group: 70.8 (9.6), n = 756 months: PiCASO Intervention Group: 74.9 (10.0), n = 1476 months: Attention Control Group: 72.8 (10.4), n = 759 months: PiCASO Intervention Group: 77.3 (10.9), n = 1479 months: Attention Control Group: 74.8 (11.3), n = 7512 months: PiCASO Intervention Group: 79.8 (11.7), n = 14712 months: Attention Control Group: 76.8 (12.1), n = 75PiCASO Intervention Group vs Attention Control Group: p = 0.5137; Multi-level mixed effects (not statistically significant against the posted threshold 0.05; outcome 2, analysis 1)Values: mean score on a scale, Standard DeviationTime frame: baseline, 3, 6, 9, and 12 months
Participants
PiCASO Intervention Group: 147 started, 99 completedAttention Control Group: 75 started, 53 completed
Serious adverse events
PiCASO Intervention Group: 0 of 147Attention Control Group: 0 of 75Participants with at least one serious adverse event, of those at risk, as posted
3 secondary outcomes
Change in Transition Readiness as Measured by the Transition Readiness Questionnaire (TRA…
Baseline: PiCASO Intervention Group 4.1 (0.5), n=147; Attention Control Group 3.9 (0.5), n=75 [mean score on a scale, Standard Deviation] (first of 5 rows) PiCASO Intervention Group vs Attention Control Group: p = 0.4107; Multi-level mixed effects
Change in Health-related Quality of Life as Measured by the Short Form Health Survey (SF1…
Baseline: PiCASO Intervention Group 45.5 (8.1), n=147; Attention Control Group 45.1 (8.3), n=75 [mean T-score, Standard Deviation] (first of 5 rows) PiCASO Intervention Group vs Attention Control Group: p = 0.1708; Multi-level mixed effects
Change in Emotional Health as Measured by the Brief Symptom Inventory (BSI 18)
Baseline: PiCASO Intervention Group 9.7 (8.7), n=147; Attention Control Group 10.7 (7.9), n=75 [mean score on a scale, Standard Deviation] (first of 5 rows) PiCASO Intervention Group vs Attention Control Group: p = 0.7982; Multi-level mixed effects

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.

Detailed description public domain (ClinicalTrials.gov)

Increases in life expectancy in almost all childhood-onset chronic conditions (COCC) has brought unique challenges for adolescents and young adults (AYA) who struggle to deal with the associated disease burden, manage therapies, and thrive as they develop independent self-management skills, and become active and engaged patients. The challenges that influence the lives of AYAs are largely adaptive, such as making lifestyle modifications, adhering to complex medication regimens, and learning to navigate the adult health system. Adding to this complexity is the need for AYAs to progressively take over greater self-management responsibilities from parents. Promoting activated self-management is critically important given that this shift in health care management from parents and health care providers to the AYA is identified as key to successful adult outcomes. Peer support interventions are well-suited to address challenges theorized as critical to AYAs given the importance of peer relationships during this time. The investigators propose a mixed-methods, five-year randomized controlled trial, that will include 225 AYAs (16-22 years) with COCCs, to test the Peer i-Coaching for Activated Self-Management Optimization (PICASO) versus an attention control group. This novel, mobile health intervention utilizes an established telephone/text based secure interface to allow AYAs access knowledge, experience, and instrumental/emotional support from a trained peer coach (18-26 years), who has already developed independence and is an active self-manager. The investigators will determine the efficacy of PICASO on self-management, patient activation, transition readiness, health-related quality, and emotional health of life across 12 months. The investigators will explore whether age, sex, race/ethnicity, chronic condition, and/or disease severity moderate the trajectory of PICASO effects on self-management, patient activation, coping, emotional health and health-related quality of life. Lastly, the investigators will explore mechanisms of the PICASO impact by describing AYA experiences with the intervention.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Change in Self-management as Measured by the Partners in Health Scale [baseline, 3, 6, 9, and 12 months]. Mean, score on a scale (Standard Deviation). Baseline: PiCASO Intervention Group (n=147): 6.7 (0.7); Attention Control Group (n=75): 6.5 (0.8). 3 months: PiCASO Intervention Group (n=147): 6.8 (0.7); Attention Control Group (n=75): 6.6 (0.8). 6 months: PiCASO Intervention Group (n=147): 6.9 (0.8); Attention Control Group (n=75): 6.6 (0.8). 9 months: PiCASO Intervention Group (n=147): 7.0 (0.8); Attention Control Group (n=75): 6.6 (0.8). 12 months: PiCASO Intervention Group (n=147): 7.1 (0.8); Attention Control Group (n=75): 6.6 (0.9). Analysis, PiCASO Intervention Group vs Attention Control Group: p=0.0034; Multi-level mixed effects; superiority.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Patient Activation as Measured by the Patient Activation Measure (PAM-13) [baseline, 3, 6, 9, and 12 months]. Mean, score on a scale (Standard Deviation). Baseline: PiCASO Intervention Group (n=147): 70.0 (8.4); Attention Control Group (n=75): 68.8 (8.7). 3 months: PiCASO Intervention Group (n=147): 72.4 (9.2); Attention Control Group (n=75): 70.8 (9.6). 6 months: PiCASO Intervention Group (n=147): 74.9 (10.0); Attention Control Group (n=75): 72.8 (10.4). 9 months: PiCASO Intervention Group (n=147): 77.3 (10.9); Attention Control Group (n=75): 74.8 (11.3). 12 months: PiCASO Intervention Group (n=147): 79.8 (11.7); Attention Control Group (n=75): 76.8 (12.1). Analysis, PiCASO Intervention Group vs Attention Control Group: p=0.5137; Multi-level mixed effects; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Change in Transition Readiness as Measured by the Transition Readiness Questionnaire (TRAQ 20) [baseline, 3, 6, 9, and 12 months]. Mean, score on a scale (Standard Deviation). Baseline: PiCASO Intervention Group (n=147): 4.1 (0.5); Attention Control Group (n=75): 3.9 (0.5). 3 months: PiCASO Intervention Group (n=147): 4.2 (0.4); Attention Control Group (n=75): 4.0 (0.5). 6 months: PiCASO Intervention Group (n=147): 4.3 (0.4); Attention Control Group (n=75): 4.1 (0.5). 9 months: PiCASO Intervention Group (n=147): 4.4 (0.4); Attention Control Group (n=75): 4.1 (0.5). 12 months: PiCASO Intervention Group (n=147): 4.4 (0.4); Attention Control Group (n=75): 4.2 (0.4). Analysis, PiCASO Intervention Group vs Attention Control Group: p=0.4107; Multi-level mixed effects; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Change in Health-related Quality of Life as Measured by the Short Form Health Survey (SF12) - Mental Component Summary (MCS) [baseline, 3, 6, 9, and 12 months]. Mean, T-score (Standard Deviation). Baseline: PiCASO Intervention Group (n=147): 45.5 (8.1); Attention Control Group (n=75): 45.1 (8.3). 3 months: PiCASO Intervention Group (n=147): 46.1 (7.8); Attention Control Group (n=75): 45.1 (8.1). 6 months: PiCASO Intervention Group (n=147): 46.7 (7.5); Attention Control Group (n=75): 45.1 (7.9). 9 months: PiCASO Intervention Group (n=147): 47.2 (7.3); Attention Control Group (n=75): 45.1 (7.7). 12 months: PiCASO Intervention Group (n=147): 47.8 (7.2); Attention Control Group (n=75): 45.1 (7.8). Analysis, PiCASO Intervention Group vs Attention Control Group: p=0.1708; Multi-level mixed effects; superiority.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Change in Emotional Health as Measured by the Brief Symptom Inventory (BSI 18) [baseline, 3, 6, 9, and 12 months]. Mean, score on a scale (Standard Deviation). Baseline: PiCASO Intervention Group (n=147): 9.7 (8.7); Attention Control Group (n=75): 10.7 (7.9). 3 months: PiCASO Intervention Group (n=147): 9.5 (9.0); Attention Control Group (n=75): 10.5 (8.1). 6 months: PiCASO Intervention Group (n=147): 9.3 (9.3); Attention Control Group (n=75): 10.4 (8.5). 9 months: PiCASO Intervention Group (n=147): 9.0 (9.8); Attention Control Group (n=75): 10.3 (8.9). 12 months: PiCASO Intervention Group (n=147): 8.8 (10.4); Attention Control Group (n=75): 10.2 (9.5). Analysis, PiCASO Intervention Group vs Attention Control Group: p=0.7982; Multi-level mixed effects; superiority.